GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jazz Pharmaceuticals PLC (STU:J7Z) » Definitions » Cyclically Adjusted Book per Share

Jazz Pharmaceuticals (STU:J7Z) Cyclically Adjusted Book per Share : €53.30 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Jazz Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Jazz Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2024 was €64.481. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €53.30 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Jazz Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 9.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 12.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 24.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Jazz Pharmaceuticals was 31.50% per year. The lowest was 12.20% per year. And the median was 25.85% per year.

As of today (2025-05-10), Jazz Pharmaceuticals's current stock price is €86.86. Jazz Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was €53.30. Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 1.63.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jazz Pharmaceuticals was 25.25. The lowest was 1.72. And the median was 5.24.


Jazz Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Jazz Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jazz Pharmaceuticals Cyclically Adjusted Book per Share Chart

Jazz Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.26 35.47 42.26 45.85 53.30

Jazz Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.85 47.56 49.77 48.53 53.30

Competitive Comparison of Jazz Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Jazz Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jazz Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=64.481/122.4391*122.4391
=64.481

Current CPI (Dec. 2024) = 122.4391.

Jazz Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201503 19.761 99.975 24.201
201506 21.055 100.573 25.633
201509 22.652 100.274 27.659
201512 23.939 99.676 29.406
201603 23.862 99.676 29.311
201606 24.903 101.072 30.168
201609 25.529 100.274 31.172
201612 29.751 99.676 36.545
201703 30.923 100.374 37.721
201706 32.599 100.673 39.647
201709 34.558 100.474 42.113
201712 38.275 100.075 46.829
201803 37.672 100.573 45.862
201806 40.747 101.072 49.361
201809 43.009 101.371 51.948
201812 42.150 100.773 51.212
201903 42.466 101.670 51.141
201906 46.628 102.168 55.879
201909 48.984 102.268 58.646
201912 49.873 102.068 59.827
202003 45.905 102.367 54.906
202006 50.309 101.769 60.527
202009 51.577 101.072 62.481
202012 53.556 101.072 64.878
202103 56.091 102.367 67.089
202106 56.110 103.364 66.465
202109 54.541 104.859 63.685
202112 56.937 106.653 65.364
202203 52.640 109.245 58.998
202206 48.352 112.779 52.494
202209 44.087 113.504 47.558
202212 46.081 115.436 48.877
202303 48.681 117.609 50.680
202306 51.330 119.662 52.521
202309 51.943 120.749 52.670
202312 55.045 120.749 55.816
202403 53.956 120.990 54.602
202406 56.611 122.318 56.667
202409 62.176 121.594 62.608
202412 64.481 122.439 64.481

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Jazz Pharmaceuticals  (STU:J7Z) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Jazz Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=86.86/53.30
=1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jazz Pharmaceuticals was 25.25. The lowest was 1.72. And the median was 5.24.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Jazz Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Jazz Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jazz Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals Headlines

No Headlines